Protein label and drug delivery system

• US 4,889,916 A
• Filed: 02/01/1988
• Issued: 12/26/1989
• Est. Priority Date: 11/19/1985
• Status: Expired due to Fees

• Current Assignee: Johns Hopkins University
• Original Assignee: Johns Hopkins University
• Inventors: Komoriya, Akira, Packard, Beverly, Edidin, Michael
• Primary Examiner(s): Kight, John
• Assistant Examiner(s): Nutter, Nathan M.
• Application Number:
  US07/151,186
• Time in Patent Office: 694 Days
• Field of Search: 525/54.1, 530/380, 530/390, 530/391, 435/181, 436/86, 436/88, 436/532
• US Class Current: 525/54.1
• CPC Class Codes: A61K 47/6889 Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment
• CPC Class Codes: C07D 311/82 Xanthenes
• CPC Class Codes: C07K 1/1077 by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
• CPC Class Codes: G01N 33/533 with fluorescent label

Abstract

A bridging molecule carrying a drug, or a label such as a fluorophore, which adds across disulfide bonds of molecules, particularly proteins, and methods of manfacturing and using the bridging molecules, are disclosed. The bridging molecule is reactive with sulfhydryl groups formed by the reduction of disulfide bonds of the protein. The functional groups of the bridging molecules are typically --SH groups.

Claims

1. A method of conjugating a protein with a bridging compound having the formula ##STR8## wherein X and Y comprise separate functional groups reactive with sulfhydryl groups formed by reduction of disulfide bonds of a protein molecule and A comprises a drug, dye or label portion which is unreactive with sulfhydryl groups, said method comprising the steps of:

(a) reducing the disulfide bonds of said protein;

(b) reacting the bridging compound across the reduced disulfide bonds of said protein; and

(c) oxidizing or alkylating the reduced disulfide bonds remaining after step (b).

2. A method as in claim 1 wherein all the steps are carried out at between room temperature and the denaturation temperature of said protein.

3. A method as in claim 1 wherein the reacting step includes the step of adding about a 100-fold excess of the bridging compound to said protein.

4. A method as in claim 3 wherein the reacting step includes the steps of incubating the bridging compound-protein mixture for about 10 minutes.

5. A method as in claim 1 wherein the oxidizing step includes the steps of bubbling oxygen gas through the solution, and dropping the pH to about 5.5.

6. A method as in claim 1 wherein the reducing step includes the step of reducing the disulfide bonds with dithiothreitol.

7. A method as in claim 1 wherein the reducing step includes the step of reducing the disulfide bonds with 2 mercapto ethanol.

8. A method as in claim 1 wherein the reducing step includes the step of mixing dithiothreitol with said protein at a ratio of from 1:

1 to 10;

1.

9. A method as in claim 1 wherein the reducing step includes the step of adding an excess of ethylenediaminetetraacetic acid.

10. A method as in claim 1 wherein the reducing step includes the step of adjusting the pH to about 8-10 and incubating for about 30 minutes.

11. A method as in claim 10 wherein the oxidizing step includes the step of keeping the solution at about room temperature for about 22 hours.

12. A method according to claim 1 where X and Y are halogen or sulfhydryl.